Copyright
©The Author(s) 2004.
World J Gastroenterol. Jan 1, 2004; 10(1): 136-142
Published online Jan 1, 2004. doi: 10.3748/wjg.v10.i1.136
Published online Jan 1, 2004. doi: 10.3748/wjg.v10.i1.136
Table 2 Baseline values of lymphocyte subpopulations in pe-ripheral blood mononuclear cells of normal control, treatment and control groups (%, (-χ±s)
| Groups | n | CD3+ | CD4+ | CD8+ | CD57+ | CD4+/CD8+ |
| Normal | 20 | 67.1 ± 6.3 | 40.2 ± 5.1 | 27.7 ± 5.0 | 18.5 ± 2.31 | 1.49/0.24 |
| control | ||||||
| Treatment | 25 | 60.8 ± 6.3b | 33.6 ± 4.2b | 30.6 ± 5.2 | 14.8 ± 4.4a | 1.15 ± 0.34b |
| Control | 24 | 60.5 ± 4.6b | 33.4 ± 3.7b | 31.0 ± 3.9a | 15.0 ± 2.8a | 1.11 ± 0.25b |
- Citation: Lin CY, Bai DJ, Yuan HY, Wang K, Yang GL, Hu MB, Wu ZQ, Li Y. Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial. World J Gastroenterol 2004; 10(1): 136-142
- URL: https://www.wjgnet.com/1007-9327/full/v10/i1/136.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i1.136